Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noah Federman

Showing results (41-50 of 111) with videos related to

Pageof 12
Sort By:
Journal of Clinical and Translational Science|May 19, 2025
Erratum: 160 Empowering future healthcare leaders and clinical researchers across a decade: UCLA's Clinical and Translational Science Institute - Research Associates Program - CORRIGENDUMOmar Selim, Tiffany Chen, Laurie Shaker-Irwin, et al.
International Journal of Hygiene and Environmental Health|May 5, 2024
Maternal residential exposure to solvents from industrial sources during pregnancy and childhood cancer risk in CaliforniaYixin Chen, Darcy Van Deventer, Roch Nianogo, et al.
Journal of Occupational and Environmental Medicine|June 7, 2024
Maternal Exposure to Heavy Metals From Industrial Sources During Pregnancy and Childhood Cancer Risk in CaliforniaYixin Chen, Darcy Van Deventer, Roch Nianogo, et al.
Molecular Oncology|June 11, 2021
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcomaPichaya Thanindratarn, Ran Wei, Dylan C Dean, et al.
Pediatric Hematology and Oncology|September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patientsFranziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Orbit (Amsterdam, Netherlands)|February 20, 2024
Orbital indeterminate cell histiocytosisAngela J Oh, Connie M Sears, Akhila A Vadivelan, et al.
Molecular Cancer Therapeutics|March 4, 2010
ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathwaysAlan K Ikeda, Dejah R Judelson, Noah Federman, et al.
Clinical Therapeutics|October 2, 2023
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study ProgramZachary Rivers, Ben Hyde, Karyn Ronski, et al.
BMJ Open|January 20, 2025
Evaluating the implementation and impact of a volunteer navigation oncology support programme: study protocol for a pragmatic, real-world hybrid type 2 studyGabrielle B Rocque, D'Ambra N Dent, Charlotte Waugh, et al.
Cancer|June 1, 2012
Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcomaNicholas M Bernthal, Noah Federman, Frederick R Eilber, et al.
Pageof 12

Showing results (41-50 of 111) with videos related to

Sort By:
Pageof 12
Journal of Clinical and Translational Science|May 19, 2025
Erratum: 160 Empowering future healthcare leaders and clinical researchers across a decade: UCLA's Clinical and Translational Science Institute - Research Associates Program - CORRIGENDUMOmar Selim, Tiffany Chen, Laurie Shaker-Irwin, et al.
International Journal of Hygiene and Environmental Health|May 5, 2024
Maternal residential exposure to solvents from industrial sources during pregnancy and childhood cancer risk in CaliforniaYixin Chen, Darcy Van Deventer, Roch Nianogo, et al.
Journal of Occupational and Environmental Medicine|June 7, 2024
Maternal Exposure to Heavy Metals From Industrial Sources During Pregnancy and Childhood Cancer Risk in CaliforniaYixin Chen, Darcy Van Deventer, Roch Nianogo, et al.
Molecular Oncology|June 11, 2021
T-LAK cell-originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcomaPichaya Thanindratarn, Ran Wei, Dylan C Dean, et al.
Pediatric Hematology and Oncology|September 23, 2011
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patientsFranziska Walter, Noah Federman, Wipapat Apichairuk, et al.
Orbit (Amsterdam, Netherlands)|February 20, 2024
Orbital indeterminate cell histiocytosisAngela J Oh, Connie M Sears, Akhila A Vadivelan, et al.
Molecular Cancer Therapeutics|March 4, 2010
ABT-869 inhibits the proliferation of Ewing Sarcoma cells and suppresses platelet-derived growth factor receptor beta and c-KIT signaling pathwaysAlan K Ikeda, Dejah R Judelson, Noah Federman, et al.
Clinical Therapeutics|October 2, 2023
Exploring Barriers to Pediatric Cancer Clinical Trials: The Role of a Networked, Just-in-Time Study ProgramZachary Rivers, Ben Hyde, Karyn Ronski, et al.
BMJ Open|January 20, 2025
Evaluating the implementation and impact of a volunteer navigation oncology support programme: study protocol for a pragmatic, real-world hybrid type 2 studyGabrielle B Rocque, D'Ambra N Dent, Charlotte Waugh, et al.
Cancer|June 1, 2012
Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcomaNicholas M Bernthal, Noah Federman, Frederick R Eilber, et al.
Pageof 12